
The AngioVac system, a vacuum-assisted aspiration device, has proven to be an effective tool for removing right-sided cardiac thrombi and has shown utility in managing complex cases of right-sided infective endocarditis and intracardiac tumors. Despite the promising outcomes reported in the short term, there needs to be more detailed data regarding long-term patient outcomes following…
Login in to view this article:
You need to be logged in to view the rest of this article. Don't have an account? Register for one below.
Subscribe
0 Comments
Oldest